[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343491-105":59,"doc-detail-343491-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","styk1-mediates-nk-cell-anti-tumor-response-through-regulating-ccr2-and-trafficking","STYK1 mediates NK cell anti-tumor response through regulating CCR2 and trafficking","","The serine/threonine/tyrosine kinase 1 (STYK1), a receptor protein-tyrosine kinase-like molecule, is implicated in tumorigenesis and metastasis across cancers. Database analysis of RTK expression in immune cells identifies STYK1 as principally expressed in NK cells. Using CRISPR/Cas9 to generate STYK1-deleted mice, the study shows normal NK cell development and function but enhanced tumor progression across multiple in vivo tumor models with reduced NK cell accumulation in tumors. Mechanistically, STYK1 deficiency lowers CCR2 expression and alters migration/adhesion signaling pathways. Overall, STYK1 expression links CCR2 regulation to NK anti-tumor response and tumor infiltration.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/styk1-mediates-nk-cell-anti-tumor-response-through-regulating-ccr2-and-trafficking/343491/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/styk1-mediates-nk-cell-anti-tumor-response-through-regulating-ccr2-and-trafficking/343491.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is STYK1 and where is it mainly expressed in immune cells?","Question",{"text":113,"@type":114},"STYK1 is a receptor protein-tyrosine kinase-like molecule implicated in tumorigenesis and metastasis. Database analysis of RTK expression indicates it is principally expressed in NK cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did STYK1 deletion affect NK cells and tumor progression in vivo?",{"text":118,"@type":114},"STYK1-deleted mice showed normal NK cell number, development, and function in tumor-free resting conditions. In multiple tumor models, STYK1 deletion promoted tumor progression and reduced NK cell accumulation in tumor tissues compared with wild-type mice.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism connects STYK1 to NK cell anti-tumor responses?",{"text":122,"@type":114},"RNA sequencing and pathway analysis indicate that STYK1 regulates signaling pathways related to migration and adhesion in NK cells. Further chemokine receptor analysis shows reduced CCR2 expression in STYK1-deficient NK cells, linking STYK1 to NK infiltration and anti-tumor activity.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},343491,1790387988,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","He etal. Journal of Translational Medicine (2024) 22:943  \n[https://doi.org/10.1186/s12967-024-05718-2](https://doi.org/10.1186/s12967-024-05718-2)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nSTYK1 mediates NK cell anti-tumor response through regulating CCR2 and trafficking  \nJunming He 1,2, Yuexi He7, Ruojia Biao8,9,10,11, Yuqing Wei8,9,10,11, Zhongjun Dong3,4,5,6,7,13* and Juan Du8,9,10,11,12*  \nAbstract  \nThe serine/threonine/tyrosine kinase 1 (STYK1) is a receptor protein-tyrosine kinase (RPTK)-like molecule that is detected in several human organs. STYK1 plays an important role in promoting tumorigenesis and metastasis in various cancers. By analyzing the expression of RTKs in immune cells in the database of 2013 Immunological Genome Project, we found that STYK1 was principally expressed in NK cells. In order to investigate the function of STYK1, we used CRISPR/Cas9 technology to generate STYK1-deleted mice, we found STYK1 deletion mice have normal number, development, and function of NK cells in spleen and bone marrow in tumor-free resting state. To examine the tumor surveillance of STYK1 in vivo, we utilized a variety of tumor models, including NK cellspecific target cell (ß2M and RMA-S) clearance experiments in vivo, subcutaneous and intravenous injection of B16F10 melanoma model, and the spontaneous breast cancer model MMTV-PyMT. Surprisingly, we discovered that deletion of the oncogenic STYK1 promoted the four-model tumor progression, and we observed a reduction of NK cell accumulation in the tumor tissues of STYK1 deletion mice compared to WT mice. In order to study the mechanism of STYK1 in NK, RNA sequence of STYK1−/− and WT NK have unveiled a disparity in the signaling pathways linked to migration and adhesion in STYK1−/− NK cells. Further analysis of chemokine receptors associated with NK cell migration revealed that STYK1-deficient NK cells exhibited a significant reduction in CCR2 expression. The STYK1 expression was negatively associated with tumor progression in glioma patients. Overall, our study found the expression of STYK1 in NK cell mediates NK cell anti-tumor response through regulating CCR2 and infiltrating into tumor tissue.  \nKeywords Serine/threonine/tyrosine kinase 1 (STYK1), Natural killer (NK) cells, Tumor infiltrating, CCR2, Progression  \n*Correspondence:  \nZhongjun Dong  \n[dongzj@mail.tsinghua.edu.cn](dongzj@mail.tsinghua.edu.cn)  \nJuan Du  \n[duj656@ccmu.edu.cn](duj656@ccmu.edu.cn)  \n1Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China  \n2Institute for Organ Transplant and Bionic Medicine, Tsinghua University, Beijing 102218, China  \n3Department of Allergy, The First Affiliated Hospital of Anhui Medical University and Institute of Clinical Immunology, Anhui Medical University, Hefei 230032, China  \n4Innovative Institute of Tumor Immunity and Medicine (lTlM),  \nHefei 230032, China  \n5Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, Hefei 230032, China  \n6Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China  \n7State Key Laboratory of Membrane Biology, School of Medicine and Institute for Immunology, Tsinghua University, Beijing 100084, China 8National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China  \n9Beijing Institute of Infectious Diseases, Beijing 100015, China 10National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China  \n11Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing 100015, China  \n12Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China 13Tsinghua University, Medical Blvd. D328, Haidian District, Beijing 100086, China  \n© The Author(s) 2024. Open Access This article is licensed under a Crea","cbCaifDNQV6UyHzF","https://ap.wps.com/l/cbCaifDNQV6UyHzF","pdf",4409626,15,"English","# Abstract\n# Background\n## STYK1 properties and role in cancer","[{\"question\":\"What is STYK1 and where is it mainly expressed in immune cells?\",\"answer\":\"STYK1 is a receptor protein-tyrosine kinase-like molecule implicated in tumorigenesis and metastasis. Database analysis of RTK expression indicates it is principally expressed in NK cells.\"},{\"question\":\"How did STYK1 deletion affect NK cells and tumor progression in vivo?\",\"answer\":\"STYK1-deleted mice showed normal NK cell number, development, and function in tumor-free resting conditions. In multiple tumor models, STYK1 deletion promoted tumor progression and reduced NK cell accumulation in tumor tissues compared with wild-type mice.\"},{\"question\":\"What mechanism connects STYK1 to NK cell anti-tumor responses?\",\"answer\":\"RNA sequencing and pathway analysis indicate that STYK1 regulates signaling pathways related to migration and adhesion in NK cells. Further chemokine receptor analysis shows reduced CCR2 expression in STYK1-deficient NK cells, linking STYK1 to NK infiltration and anti-tumor activity.\"}]","STYK1 mediates NK cell anti-tumor response through regulating CCR2 and trafficking | PDF",1790051307,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/956d6d6fd24e9aa16427cb0b328844a8.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6736b6f171da76bfe8b6c7362e45b92.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/640ea627733eff50e31e2fa6f8e18f17.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e060eb123224b640b92c24d72144fdd.webp",980,1306]